BioSpace News Archive

Satsuma Pharmaceuticals, Inc. has announced the pricing of its initial public offering of 5,500,000 shares of common stock at a public offering price of $15.00 per share, for gross proceeds of $82.5 million, before the underwriting discounts and commissions.

Akari Therapeutics, Plc announced that the U.S. Food and Drug Administration has granted orphan drug designation for nomacopan for the treatment of bullous pemphigoid.

Lysando AG, market leader for antimicrobial proteins based in Liechtenstein, has established an Ethical Committee, composed of two renowned members, who will serve on a voluntary basis, Leonhard Stärk and Dr. Karl Liese.

New facilities expand services offering to Irish and International customers

Clinical Utility Study will Evaluate the Prolaris® Test in Men with Prostate Cancer

Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced a significant expansion of its presence in Nevada and Arizona through the signing of a purchase agreement to acquire certain assets (the “Transaction”) from Tryke Companies, LLC

MedPower picks former SiriusXM executive, Matt Downing, to lead global marketing for mobile microlearning services.

This event is part of the ongoing Psychogenic non-epileptic seizures (PNES) Awareness Campaign NEREG offers in New York to promote education and visibility for this critical health condition

Canadian Breast Cancer Network and Self Care Catalysts announce strategic partnership, collaborating on expanding Breast Cancer literacy through a patient engagement, health tracking platform and real-world evidence research. [16-September-2019] OTTAWA, Canada and TORONTO , Sept. 16 2019 /PRNewswire/ -- Canadian Breast Cancer Network and Self Care Catalysts are plea

Results presented at ASTRO Annual Meeting evaluate clinical utility of 18F-fluciclovine PET/CT imaging in men with recurrent prostate cancer